U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556146) titled 'Dressing Methods in Inoperable Malignant Wounds' on April 10.
Brief Summary: This randomized controlled study aimed to evaluate symptom burden and quality of life in oncology patients with inoperable malignant wounds. Patients were assigned to receive either polyhexamethylene biguanide (PHMB)-containing dressings or paraffin-based tulle dressings. Symptom severity and quality of life were assessed over a three-month follow-up period using standardized measures, including the Edmonton Symptom Assessment Scale (ESAS). The study primarily focuses on palliative outcomes rather than wound healing.
Study Start Date: Dec. 30, 2023
Study...